| ■ 영문 제목 : Global Verapamil Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02213 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 90 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 베라파밀의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (정제, 캡슐, 주사, 기타)와 용도별 시장규모 (병원 약국, 소매 약국, 온라인 판매, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 베라파밀 시장 점유율 - 지역별 베라파밀 시장규모 - 주요지역의 종류별 시장규모 (정제, 캡슐, 주사, 기타) - 주요지역의 용도별 시장규모 (병원 약국, 소매 약국, 온라인 판매, 기타) - 미주의 베라파밀 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 베라파밀 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 베라파밀 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 베라파밀 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 베라파밀 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) REPLEK FARM, Mylan, Abbott Laboratories, YUNGSHIN PHARM IND. CO. LTD, The Central Pharmaceutical CO.,Ltd.Tianjin - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Verapamil will have significant change from previous year. By the most conservative estimates of global Verapamil market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Verapamil market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Verapamil market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablets
Capsules
Injection
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacy
Retail Pharmacy
Online Sales
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
REPLEK FARM
Mylan
Abbott Laboratories
YUNGSHIN PHARM IND. CO. LTD
The Central Pharmaceutical CO.,Ltd.Tianjin
1 Scope of the Report 2 Executive Summary 3 Global Verapamil by Company 4 Verapamil by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Verapamil Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Verapamil Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Tablets Table 3. Major Players of Capsules Table 4. Major Players of Injection Table 5. Major Players of Others Table 6. Global Verapamil Sales by Type (2016-2021) & (K Units) Table 7. Global Verapamil Sales Market Share by Type (2016-2021) Table 8. Global Verapamil Revenue by Type (2016-2021) & ($ million) Table 9. Global Verapamil Revenue Market Share by Type (2016-2021) Table 10. Global Verapamil Sale Price by Type (2016-2021) Table 11. Global Verapamil Sales by Sales Channel (2016-2021) & (K Units) Table 12. Global Verapamil Sales Market Share by Sales Channel (2016-2021) Table 13. Global Verapamil Value by Sales Channel (2016-2021) Table 14. Global Verapamil Revenue Market Share by Sales Channel (2016-2021) Table 15. Global Verapamil Sale Price by Sales Channel (2016-2021) Table 16. Global Verapamil Sales by Company (2019-2021) & (K Units) Table 17. Global Verapamil Sales Market Share by Company (2019-2021) Table 18. Global Verapamil Revenue by Company (2019-2021) ($ Millions) Table 19. Global Verapamil Revenue Market Share by Company (2019-2021) Table 20. Global Verapamil Sale Price by Company (2019-2021) Table 21. Key Manufacturers Verapamil Producing Area Distribution and Sales Area Table 22. Players Verapamil Products Offered Table 23. Verapamil Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Verapamil Sales by Region (2016-2021) (K Units) Table 27. Global Verapamil Sales Market Share by Region (2016-2021) Table 28. Global Verapamil Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Verapamil Revenue Market Share by Region (2016-2021) Table 30. Americas Verapamil Sales by Country (2016-2021) & (K Units) Table 31. Americas Verapamil Sales Market Share by Country (2016-2021) Table 32. Americas Verapamil Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Verapamil Revenue Market Share by Country (2016-2021) Table 34. Americas Verapamil Sales by Type (2016-2021) & (K Units) Table 35. Americas Verapamil Sales Market Share by Type (2016-2021) Table 36. Americas Verapamil Sales by Sales Channel (2016-2021) & (K Units) Table 37. Americas Verapamil Sales Market Share by Sales Channel (2016-2021) Table 38. APAC Verapamil Sales by Region (2016-2021) & (K Units) Table 39. APAC Verapamil Sales Market Share by Region (2016-2021) Table 40. APAC Verapamil Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Verapamil Revenue Market Share by Region (2016-2021) Table 42. APAC Verapamil Sales by Type (2016-2021) & (K Units) Table 43. APAC Verapamil Sales Market Share by Type (2016-2021) Table 44. APAC Verapamil Sales by Sales Channel (2016-2021) & (K Units) Table 45. APAC Verapamil Sales Market Share by Sales Channel (2016-2021) Table 46. Europe Verapamil Sales by Country (2016-2021) & (K Units) Table 47. Europe Verapamil Sales Market Share by Country (2016-2021) Table 48. Europe Verapamil Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Verapamil Revenue Market Share by Country (2016-2021) Table 50. Europe Verapamil Sales by Type (2016-2021) & (K Units) Table 51. Europe Verapamil Sales Market Share by Type (2016-2021) Table 52. Europe Verapamil Sales by Sales Channel (2016-2021) & (K Units) Table 53. Europe Verapamil Sales Market Share by Sales Channel (2016-2021) Table 54. Middle East & Africa Verapamil Sales by Country (2016-2021) & (K Units) Table 55. Middle East & Africa Verapamil Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Verapamil Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Verapamil Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Verapamil Sales by Type (2016-2021) & (K Units) Table 59. Middle East & Africa Verapamil Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa Verapamil Sales by Sales Channel (2016-2021) & (K Units) Table 61. Middle East & Africa Verapamil Sales Market Share by Sales Channel (2016-2021) Table 62. Key and Potential Regions of Verapamil Table 63. Key Application and Potential Industries of Verapamil Table 64. Key Challenges of Verapamil Table 65. Key Trends of Verapamil Table 66. Verapamil Distributors List Table 67. Verapamil Customer List Table 68. Global Verapamil Sales Forecast by Region (2021-2026) & (K Units) Table 69. Global Verapamil Consumption Market Forecast by Region Table 70. Global Verapamil Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Verapamil Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Verapamil Sales Forecast by Country (2021-2026) & (K Units) Table 73. Americas Verapamil Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Verapamil Sales Forecast by Region (2021-2026) & (K Units) Table 75. APAC Verapamil Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Verapamil Sales Forecast by Country (2021-2026) & (K Units) Table 77. Europe Verapamil Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Verapamil Sales Forecast by Country (2021-2026) & (K Units) Table 79. Middle East & Africa Verapamil Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Verapamil Sales Forecast by Type (2021-2026) & (K Units) Table 81. Global Verapamil Sales Market Share Forecast by Type (2021-2026) Table 82. Global Verapamil Revenue Forecast by Type (2021-2026) & ($ Millions) Table 83. Global Verapamil Revenue Market Share Forecast by Type (2021-2026) Table 84. Global Verapamil Sales Forecast by Sales Channel (2021-2026) & (K Units) Table 85. Global Verapamil Sales Market Share Forecast by Sales Channel (2021-2026) Table 86. Global Verapamil Revenue Forecast by Sales Channel (2021-2026) & ($ Millions) Table 87. Global Verapamil Revenue Market Share Forecast by Sales Channel (2021-2026) Table 88. REPLEK FARM Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors Table 89. REPLEK FARM Verapamil Product Offered Table 90. REPLEK FARM Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 91. REPLEK FARM Main Business Table 92. REPLEK FARM Latest Developments Table 93. Mylan Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors Table 94. Mylan Verapamil Product Offered Table 95. Mylan Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 96. Mylan Main Business Table 97. Mylan Latest Developments Table 98. Abbott Laboratories Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors Table 99. Abbott Laboratories Verapamil Product Offered Table 100. Abbott Laboratories Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 101. Abbott Laboratories Main Business Table 102. Abbott Laboratories Latest Developments Table 103. YUNGSHIN PHARM IND. CO. LTD Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors Table 104. YUNGSHIN PHARM IND. CO. LTD Verapamil Product Offered Table 105. YUNGSHIN PHARM IND. CO. LTD Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 106. YUNGSHIN PHARM IND. CO. LTD Main Business Table 107. YUNGSHIN PHARM IND. CO. LTD Latest Developments Table 108. The Central Pharmaceutical CO.,Ltd.Tianjin Basic Information, Verapamil Manufacturing Base, Sales Area and Its Competitors Table 109. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Product Offered Table 110. The Central Pharmaceutical CO.,Ltd.Tianjin Verapamil Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 111. The Central Pharmaceutical CO.,Ltd.Tianjin Main Business Table 112. The Central Pharmaceutical CO.,Ltd.Tianjin Latest Developments List of Figures Figure 1. Picture of Verapamil Figure 2. Verapamil Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Verapamil Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Verapamil Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Verapamil Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Tablets Figure 10. Product Picture of Capsules Figure 11. Product Picture of Injection Figure 12. Product Picture of Others Figure 13. Global Verapamil Sales Market Share by Type in 2020 Figure 14. Global Verapamil Revenue Market Share by Type (2016-2021) Figure 15. Verapamil Consumed in Hospital Pharmacy Figure 16. Global Verapamil Market: Hospital Pharmacy (2016-2021) & (K Units) Figure 17. Verapamil Consumed in Retail Pharmacy Figure 18. Global Verapamil Market: Retail Pharmacy (2016-2021) & (K Units) Figure 19. Verapamil Consumed in Online Sales Figure 20. Global Verapamil Market: Online Sales (2016-2021) & (K Units) Figure 21. Verapamil Consumed in Others Figure 22. Global Verapamil Market: Others (2016-2021) & (K Units) Figure 23. Global Verapamil Sales Market Share by Sales Channel (2016-2021) Figure 24. Global Verapamil Revenue Market Share by Sales Channel in 2020 Figure 25. Verapamil Revenue Market by Company in 2020 ($ Million) Figure 26. Global Verapamil Revenue Market Share by Company in 2020 Figure 27. Global Verapamil Sales Market Share by Regions (2016-2021) Figure 28. Global Verapamil Revenue Market Share by Region in 2020 Figure 29. Americas Verapamil Sales 2016-2021 (K Units) Figure 30. Americas Verapamil Revenue 2016-2021 ($ Millions) Figure 31. APAC Verapamil Sales 2016-2021 (K Units) Figure 32. APAC Verapamil Revenue 2016-2021 ($ Millions) Figure 33. Europe Verapamil Sales 2016-2021 (K Units) Figure 34. Europe Verapamil Revenue 2016-2021 ($ Millions) Figure 35. Middle East & Africa Verapamil Sales 2016-2021 (K Units) Figure 36. Middle East & Africa Verapamil Revenue 2016-2021 ($ Millions) Figure 37. Americas Verapamil Sales Market Share by Country in 2020 Figure 38. Americas Verapamil Revenue Market Share by Country in 2020 Figure 39. Americas Verapamil Sales Market Share by Type in 2020 Figure 40. Americas Verapamil Sales Market Share by Sales Channel in 2020 Figure 41. United States Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 42. Canada Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 43. Mexico Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 44. Brazil Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 45. APAC Verapamil Sales Market Share by Region in 2020 Figure 46. APAC Verapamil Revenue Market Share by Regions in 2020 Figure 47. APAC Verapamil Sales Market Share by Type in 2020 Figure 48. APAC Verapamil Sales Market Share by Sales Channel in 2020 Figure 49. China Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 50. Japan Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 51. Korea Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 52. Southeast Asia Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 53. India Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 54. Australia Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 55. Europe Verapamil Sales Market Share by Country in 2020 Figure 56. Europe Verapamil Revenue Market Share by Country in 2020 Figure 57. Europe Verapamil Sales Market Share by Type in 2020 Figure 58. Europe Verapamil Sales Market Share by Sales Channel in 2020 Figure 59. Germany Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 60. France Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 61. UK Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 62. Italy Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 63. Russia Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 64. Middle East & Africa Verapamil Sales Market Share by Country in 2020 Figure 65. Middle East & Africa Verapamil Revenue Market Share by Country in 2020 Figure 66. Middle East & Africa Verapamil Sales Market Share by Type in 2020 Figure 67. Middle East & Africa Verapamil Sales Market Share by Sales Channel in 2020 Figure 68. Egypt Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 69. South Africa Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 70. Israel Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 71. Turkey Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 72. GCC Country Verapamil Revenue Growth 2016-2021 ($ Millions) Figure 73. Channels of Distribution Figure 74. Distributors Profiles |
| ※본 조사보고서 [세계의 베라파밀 시장예측 2021년-2026년] (코드 : LPI-2201K02213) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 베라파밀 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |